固形がん患者におけるGSK5460025単独または他の抗がん剤との併用投与の安全性および予備的有効性を検討する試験

基本情報

NCT ID

NCT07213609

ステータス

募集中

試験のフェーズ

第1/第2相

試験タイプ

介入

目標被験者数

47

治験依頼者名

GlaxoSmithKline

概要

Solid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic characteristics that can make them more aggressive and challenging to treat. The study will test whether GSK5460025 alone or in combination (potential combinations may be included in future amendments to the protocol) with other anti-cancer agents can decrease tumor size, is safe, well-tolerated, and how the drug is processed in the body over time.

対象疾患

介入

依頼者（Sponsor）

実施施設 (4)